Hofmeisteria schaffneri is used in Mexican folk medicine for treating painful gastric complaints. Therefore, in this paper the smooth muscle relaxant effect of the essential oil, and an infusion of the whole plant were evaluated using the gastrointestinal transit test in mice. The results revealed that both preparations at 316 mg/kg inhibited gastrointestinal transit by 47.5 and 52.1%, respectively. The common component of the infusion and essential oil was 8,9-epoxy-10acetoxythymol angelate (2), which inhibited the gastrointestinal transit by 53.4% at a dose of 31.6 mg/kg. An HPLC-UV method was developed and validated to quantify 2. The chromatographic conditions were: A LiChrospher ® 100 RP-18 column (250 × 4 mm i.d., 5 μm) with a mobile phase composed of CH 3 CN-H 2 O, in a gradient run at a flow rate of 0.6 mL/min, using a wavelength of 215 nm. The method was linear, precise, accurate, and showed excellent recovery. According to the results, compound 2 can be used as a marker for the quality control procedures of the crude drug of H. schaffneri.
Hofmeisteria schaffneri (A. Gray) R.M. King & H. Robinson (Asteraceae) is widely used for treating painful gastrointestinal complaints in Mexico. The curative properties attributed to the plant prompted us to carry out the evaluation of its effects as an antinociceptive and antimicrobial agent [1, 2] . The infusion and essential oil showed good activity in these evaluations; phytochemical analysis of both preparations revealed the presence of thymol derivatives 15: hofmeisterin III (1), 8,9-epoxy-10acetoxythymol angelate (2) , thymol isovalerate (3), thymol isobutyrate (4), and 8,9-epoxy-10-hydroxythymol angelate (5) [1, 3] . GC-FID analysis of the essential oil revealed that compounds 1 and 2 were the most abundant [2] . In order to complete the preclinical efficacy studies of H. schaffneri, we now report the spasmolytic effect of both preparations and major components using an in vivo mouse gastrointestinal transit test [4] . In addition, a suitable HPLC-UV analytical method to quantify compound 2 in the infusion was developed. Table 1 , the essential oil and infusion of the plant exhibited spasmolytic activity since they inhibited the gastrointestinal transit in a dose-dependent manner when tested in a range of doses between 10 and 316 mg/kg. Loperamide and atropine were used as positive controls (Table 1) . Compounds 14 were also tested, but only 2 was active retarding the intestinal transit by 53.4% at the dose of 31.6 mg/kg. Compound 5 was not assayed due to its chemical instability. Although thymol itself has shown spasmolytic properties [5] , this is the first report of the spasmolytic activity of compound 2. Apparently, the highly oxidized isopropyl moiety in 2 confers this derivative the highest spasmolytic action. (Figure 1 ) revealed that 2 and 5 were the major thymol derivatives in the preparation. Therefore, a suitable method for the quantification of 2 was developed and validated according to the International Conference on Harmonization (ICH) Data are expressed as the mean ± SEM (n = 6). ANOVA followed by Dunnett post-hoc * P< 0.05, ** P< 0.01, and *** P< 0.001.
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guidelines [6] . Table 2 summarizes the validation report of the method for determination of compound 2. The method was linear, precise and accurate, and successfully applied to quantify compound 2.
H. schaffneri possesses compounds with antinociceptive, spasmolytic and antimicrobial properties. Altogether, these effects support the use of this species for treating painful gastrointestinal complaints in Mexican folk medicine. A fast and reliable method for quality control of the crude drug of H. schaffneri was developed; this issue is relevant because the efficacy and safety of crude drugs are based on the standardization of their composition. 
Experimental
Extraction and isolation:
The aerial parts of H. schaffneri were collected in Ozumba, Estado de México, México in October 2010. An authenticated voucher specimen (Bye & Linares 2678) was deposited in the National Herbarium (MEXU), Instituto de Biología, UNAM. An infusion from the aerial parts (252 g) was prepared as previously described [1] and partitioned with CH 2 Cl 2 (3.0 L × 3); 1.8 g of a CH 2 Cl 2 soluble fraction was obtained. The essential oil (190 mg) was prepared as previously described from 250 g of dried aerial parts [2] . Compounds 14 were obtained as previously described [13]. The purity of compound 2 (> 98%.) was determined by HPLC analysis using the normalization method.
Method validation:
HPLC was performed using a Waters instrument equipped with a 2487 UV-dual detector. System control, data collection and processing were accomplished using Waters Empower 2 software. An HPLC column Hibar® RT LiChrospher® 100 RP-18 (Merck), (250 × 4 mm i.d., 5 μm) with a guard column (Hibar ® LiChroCART ® 4-4, Merck) was used. Elution was carried out at room temperature at a flow rate of 0.6 mL/min with CH 3 CN (A) and H 2 O (B). The injection volume was 20 L. The elution gradient was set as follow: 45% A 07 min, 55 % A 12 min, 60% A at 17 min 65% A at 22 min, 68% at 40 min. The detection wavelength was 215 nm. The CH 2 Cl 2 fraction (15 mg) was dissolved in 15 mL of CH 3 CN (working solution, 1 mg/mL).
Standard stock solutions (1250 g/mL) of compound 2 were prepared and diluted with CH 3 CN to obtain appropriate concentrations for establishment of calibration curves. The analytical method was validated for linearity, accuracy, precision, limit of detection (LOD), limit of quantification (LOQ) and specificity, in accordance with ICH guidelines [6] .
Pharmacological study: ICR male mice (2025 g) were purchased from Centro UNAM-Harlan (now Envigo), housed under standard laboratory conditions, and maintained on standard pellet diet and water ad libitum. Procedures involving animals and their care were conducted in compliance with international rules. The institutional Committee for Care and Use of Laboratory Animals approved the experimental protocols (FQ/CICUAL/021/11). The effect of extracts and compounds on the intestinal motility was evaluated using a standard protocol [5] . The essential oil (10316 mg/kg), infusion (10316 mg/kg) and pure compounds [hofmeisterin III (1, 131.6), 8,9-epoxy-10-acetoxythymol angelate (2, 5.631.6 mg/kg), thymol isovalerate (3, 5.631.6 mg/kg) and thymol isobutyrate (4, 5.631.6 mg/kg)] were suspended in vehicle (0.9% saline solution and Tween 80 ® at 0.5%). Loperamide (5.6 mg/kg) and atropine (3.0 mg/kg) were used as positive controls. All groups were orally administered at 0.1 mL/10 g. Fifteen min after drug administration the animals were orally administrated with 0.5 mL of charcoal meal (3% charcoal in 5% of acacia gum suspension). After 20 min, all animals were sacrificed by cervical dislocation and the entire length of the small intestines, from the pylorus to the caecum, removed carefully. The distance travelled by the charcoal plug in the intestine and the total length of the intestine were measured for each mouse. The % of charcoal meal advance was calculated using the following formula:
where A is the distance travelled of the charcoal and B is the total length of the intestine.
Percentage of inhibition was calculated with the following formula: % Inhibition = ((PGT1-PGT2)/PGT1) × 100
where PGT1 is the percentage of gastrointestinal transit in VEH and PGT2 is the percentage of gastrointestinal transit in the sample.
Statistical analysis:
Results are expressed as the mean ± SEM of 6 animals in each group. Analysis of variance (ANOVA, one way) was used to analyze statistical differences; followed by Dunnett´s test (* P< 0.05, ** P< 0.01, and *** P< 0.001).
